Literature DB >> 9622938

[A new inherited metabolic disease: delta1-pyrroline 5-carboxylate synthetase deficiency].

P Kamoun1, B Aral, J M Saudubray.   

Abstract

delta 1-pyrroline 5-carboxylate synthetase (P5C synthetase) catalyzes the ATP and the NAD(P)H-dependent conversion of L-glutamate to glutamate semialdehyde (GSA) which is the metabolic precursor for proline biosynthesis. We described in two siblings a paradoxical hyperammonemia with hypoprolinemia and hypoornithinemia associated to bilateral cataract, mental retardation, joint laxity and skin hyperelasticity. We cloned human P5C synthetase-cDNA by database cloning strategy: this cDNA has an open reading frame of 2,385 bases coding for a polypeptide of 795 amino acids. Both patients are homozygous for an L396S substitution, this amino acid being highly conserved across species. This is the first report of a P5C synthetase deficiency in human.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622938

Source DB:  PubMed          Journal:  Bull Acad Natl Med        ISSN: 0001-4079            Impact factor:   0.144


  13 in total

1.  A risk factor for chronic mild hyperammonaemia.

Authors:  Pierre Kamoun; Daniel Rabier; Jean-Marie Saudubray
Journal:  Eur J Pediatr       Date:  2002-04       Impact factor: 3.183

2.  Glutamate-related gene expression changes with age in the mouse auditory midbrain.

Authors:  Sherif F Tadros; Mary D'Souza; Martha L Zettel; Xiaoxia Zhu; Nicole C Waxmonsky; Robert D Frisina
Journal:  Brain Res       Date:  2006-11-17       Impact factor: 3.252

3.  In Vivo Exposures to Particulate Matter Collected from Saudi Arabia or Nickel Chloride Display Similar Dysregulation of Metabolic Syndrome Genes.

Authors:  Jason Brocato; Michelle Hernandez; Freda Laulicht; Hong Sun; Magdy Shamy; Mansour A Alghamdi; Mamdouh I Khoder; Thomas Kluz; Lung-Chi Chen; Max Costa
Journal:  J Toxicol Environ Health A       Date:  2015

4.  Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway.

Authors:  Gregory R Kardos; Hannah C Wastyk; Gavin P Robertson
Journal:  Mol Cancer Res       Date:  2015-06-16       Impact factor: 5.852

5.  Delta1-pyrroline-5-carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline.

Authors:  Matthias R Baumgartner; Daniel Rabier; Marie-Cécile Nassogne; Jean-Louis Dufier; Jean-Paul Padovani; Pierre Kamoun; David Valle; Jean-Marie Saudubray
Journal:  Eur J Pediatr       Date:  2004-10-28       Impact factor: 3.183

Review 6.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  Human Delta1-pyrroline-5-carboxylate synthase: function and regulation.

Authors:  C-A A Hu; S Khalil; S Zhaorigetu; Z Liu; M Tyler; G Wan; D Valle
Journal:  Amino Acids       Date:  2008-04-10       Impact factor: 3.520

Review 8.  Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.

Authors:  Satori A Marchitti; Chad Brocker; Dimitrios Stagos; Vasilis Vasiliou
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-06       Impact factor: 4.481

Review 9.  Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress.

Authors:  Surendra Singh; Chad Brocker; Vindhya Koppaka; Ying Chen; Brian C Jackson; Akiko Matsumoto; David C Thompson; Vasilis Vasiliou
Journal:  Free Radic Biol Med       Date:  2012-11-27       Impact factor: 7.376

Review 10.  Substrate channeling in proline metabolism.

Authors:  Benjamin W Arentson; Nikhilesh Sanyal; Donald F Becker
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.